TY - JOUR
T1 - Use of crystalloids and colloids in Europe per year from 2010 to 2019
T2 - Protocol for an international descriptive study
AU - Zellweger, Núria M
AU - Hylander Møller, Morten
AU - Ellekjaer, Karen Louise
AU - Jonsson, Andreas Bender
AU - Bruun Svan, Kathrine
AU - Siegemund, Martin
AU - Perner, Anders
N1 - © 2021 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
PY - 2021/11
Y1 - 2021/11
N2 - INTRODUCTION: Intravenous (IV) fluids are widely used in everyday clinical practice. In the last two decades, several trials and clinical practice guidelines have been published on the use of different types and dosages of IV fluid. This may have led to a change in clinical practice. Thus, we aim to describe the use of IV crystalloids and colloids in Europe over a 10-year period.METHODS AND ANALYSIS: We will collect national or regional data on the use of IV crystalloids and colloids in European hospitals through companies and/or federal medical agencies that provide pharmaceutical data concerning the type and amount of fluids used from January 1st, 2010 to December 31st, 2019. We will use run charts to describe time trends in the use of fluids.CONCLUSION: This study will provide insight into the use of IV fluids in Europe between 2010 and 2019. It will enable the observation of changes over time and among the different European countries and regions. This will provide information on the extent to which landmark trials and clinical practice guidelines on fluids have affected clinical practice in Europe regarding the use of IV fluids.
AB - INTRODUCTION: Intravenous (IV) fluids are widely used in everyday clinical practice. In the last two decades, several trials and clinical practice guidelines have been published on the use of different types and dosages of IV fluid. This may have led to a change in clinical practice. Thus, we aim to describe the use of IV crystalloids and colloids in Europe over a 10-year period.METHODS AND ANALYSIS: We will collect national or regional data on the use of IV crystalloids and colloids in European hospitals through companies and/or federal medical agencies that provide pharmaceutical data concerning the type and amount of fluids used from January 1st, 2010 to December 31st, 2019. We will use run charts to describe time trends in the use of fluids.CONCLUSION: This study will provide insight into the use of IV fluids in Europe between 2010 and 2019. It will enable the observation of changes over time and among the different European countries and regions. This will provide information on the extent to which landmark trials and clinical practice guidelines on fluids have affected clinical practice in Europe regarding the use of IV fluids.
KW - Colloids
KW - Crystalloid Solutions
KW - Fluid Therapy
KW - Humans
KW - Isotonic Solutions
KW - Plasma Substitutes/therapeutic use
KW - Rehydration Solutions
UR - http://www.scopus.com/inward/record.url?scp=85112780785&partnerID=8YFLogxK
U2 - 10.1111/aas.13955
DO - 10.1111/aas.13955
M3 - Journal article
C2 - 34310693
SN - 0001-5172
VL - 65
SP - 1514
EP - 1517
JO - Acta Anaesthesiologica Scandinavica
JF - Acta Anaesthesiologica Scandinavica
IS - 10
ER -